论文部分内容阅读
观察微生态调节剂（妈咪爱）干预母乳性黄疸疗效,并探讨疗其机制,检测“妈咪爱”治疗前后血清和十二指肠液胆红素值、胆汁和粪便β-葡萄糖醛酸苷酶（β-GD）活性。结果显示:“妈咪爱”制剂干预组血清总胆红素值从130.60±20.06μmol/L下降到61.20±16.04μmol/L（P<0.05）,十二指肠液β-GD从1859.91±908.60U/100ml下降到858.26±260.90U/100ml,粪便中β-GD从4053±983.0U/100ml下降到2110.9±1541U/100ml（P<0.05）;而对照组十二指肠液胆红素值则无明显变化（P>0.05）。可以结论,“妈咪爱”调节剂能降低血清总胆红素值和肠道及胆汁中β-GD活性。
To observe the effect of microecological regulator (Mommy Love) on the intervention of breast milk jaundice and to explore the mechanism of its treatment. The serum and duodenal fluid bilirubin, bile and fecal β-glucuronide Enzyme (β-GD) activity. The results showed that the serum total bilirubin value in the intervention group decreased from 130.60 ± 20.06μmol / L to 61.20 ± 16.04μmol / L (P <0.05), and the β-GD in duodenal juice increased from 1859.91 ± 908.60U / 100ml decreased to 858.26 ± 260.90U / 100ml, β-GD in feces decreased from 4053 ± 983.0U / 100ml to 2110.9 ± 1541U / 100ml (P <0.05); while the control group, duodenal fluid bilirubin value was not significantly Change (P> 0.05). It can be concluded that “Mommy Love” modulators reduce serum total bilirubin values and β-GD activity in the gut and bile.